Chromavision Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Automated cell-imaging systems manufacturer's planned $12 mil. private placement includes completed sale of approximately 560,693 newly issued shares of common stock at $12.48 each and warrants to purchase 56,070 additional shares. The firm also has agreed to issue additional shares to one of its investors before Dec. 31, 2000 for a total purchase price of $5 mil. Proceeds will be used for working capital and continued commercialization of the ACIS automated cell-imaging system